August 23, 2018
Joint Commission revises requirements for medication compounding
Editor's Note
The Joint Commission announced on August 22 that several revisions will be implemented to the Medication Compounding Certification program and Home Care Accreditation program’s Medication Compounding chapter, effective January 1, 2019.
The revisions were made to maintain consistency with current United States Pharmacopeia (USP) 795 (Pharmaceutical Compounding−Nonsterile Preparations) and USP 797 (Pharmaceutical Compounding−Sterile Preparations) requirements.
Free Daily News
- Neurosurgery trial: Early evacuation improves long-term hemorrhage outcomes
- Drug shortages higher than ever
- FDA announces class 1 recalls for premixed embolic, infusion pump software
- Academic medical centers identify performance-improvement priorities
- Propofol anesthesia for colonoscopy could help find polyps, prevent cancer
- FDA Class 1 recall renews concern about historically problematic heart pumps
- New physician compensation report reveals modest pay gains but growing discontent with the profession
- Surge in corporate ownership of medical practices raises concerns over physician autonomy, care quality
- How Minneapolis healthcare real estate remained strong amid challenges, shifts in patient care preferences: Lessons for other states
- Artificial intelligence (AI) captures uncertainty in medical scans
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity, Equity, Inclusion & Belonging